INTERCEPT 2001 Achievements
INTERCEPT Platelet System
- Completed US Phase III pivotal trial for the initiation of US modular PMA submission
- Completed regulatory filings in Canada and Australia
- Completed agreement with Haemonetics for direct access to their platelet doses
INTERCEPT Plasma System
- Completed US Phase III a & b pivotal trials
INTERCEPT Red Blood Cell System
- Successful completion of Phase Ic trial allowed us to directly enter Phase III